Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Taurine and hypotaurine metabolism	3/11	0.015204352818016067	1.0	0	0	5.454545454545454	22.833673759197463	GGT7;CSAD;BAAT
Primary bile acid biosynthesis	3/17	0.05017800549335433	1.0	0	0	3.5294117647058822	10.56062995015536	HSD3B7;BAAT;CYP7A1
Glutathione metabolism	6/56	0.059923284693461636	1.0	0	0	2.142857142857143	6.031478835629902	GSTM2;GGT7;GSTO1;GSS;MGST2;LAP3
Vasopressin-regulated water reabsorption	5/44	0.06726261217595207	1.0	0	0	2.2727272727272725	6.134433491895637	DCTN6;DYNC1LI1;ARHGDIG;PRKACB;DYNLL2
Fluid shear stress and atherosclerosis	11/139	0.08883451839382546	1.0	0	0	1.58273381294964	3.8317668809376055	MEF2A;IKBKB;GSTM2;MIR10A;HSP90AB1;GSTO1;SUMO3;IL1B;RAC2;MGST2;RELA
Hippo signaling pathway	12/160	0.10547689674789608	1.0	0	0	1.4999999999999998	3.3738950073285414	PATJ;WNT10A;CCND2;RASSF2;SERPINE1;PPP2R2D;SCRIB;DCHS1;CSNK1E;FRMD1;LLGL2;GDF7
Ras signaling pathway	16/232	0.12111912283622606	1.0	0	0	1.379310344827586	2.9116975605853206	SHC4;PLA2G2D;CSF1;FLT3;RELA;FGF3;GNG13;GRIN1;IKBKB;GNB2;FGF18;RAC2;RIN1;PRKACB;FGFR3;SOS2
RNA transport	12/165	0.12430307174535642	1.0	0	0	1.4545454545454544	3.0327746449727915	NUP214;EIF2B5;UPF2;NDC1;EIF5B;EIF2B2;SUMO3;EIF3G;CASC3;EIF1B;NUP58;EIF4B
Glycosylphosphatidylinositol (GPI)-anchor biosynthesis	3/25	0.1269942219814603	1.0	0	0	2.4	4.9526728554420085	PIGQ;PIGM;PIGH
Nicotine addiction	4/40	0.1379595947094308	1.0	0	0	2.0	3.961588857315027	GRIN3A;GABRD;GABRG3;GRIN1
Legionellosis	5/55	0.13937991022954382	1.0	0	0	1.8181818181818181	3.582821649166955	CASP8;HSPA1L;IL1B;BNIP3;RELA
Toll-like receptor signaling pathway	8/104	0.14927432324369838	1.0	0	0	1.5384615384615385	2.9261070310469814	MAP2K3;IKBKB;CASP8;TOLLIP;IL1B;RIPK1;TICAM1;RELA
Necroptosis	11/162	0.18832482269682763	1.0	0	0	1.3580246913580245	2.267340406691085	HSP90AB1;CASP8;H2AFY;USP21;IL1B;CHMP3;RIPK1;RBCK1;TICAM1;CHMP6;JAK3
Cytosolic DNA-sensing pathway	5/63	0.20636211070548938	1.0	0	0	1.5873015873015872	2.504956879983314	IKBKB;IL1B;TREX1;RIPK1;RELA
Hedgehog signaling pathway	4/47	0.20718336704116536	1.0	0	0	1.7021276595744679	2.679406036964871	GRK2;CCND2;CSNK1E;PRKACB
Sphingolipid metabolism	4/47	0.20718336704116536	1.0	0	0	1.7021276595744679	2.679406036964871	SGPL1;CERS5;CERK;CERS2
Selenocompound metabolism	2/17	0.20773987788556972	1.0	0	0	2.352941176470588	3.6975731035436015	TXNRD2;SEPHS1
Endocrine and other factor-regulated calcium reabsorption	4/48	0.21779787247025076	1.0	0	0	1.6666666666666665	2.540313061339135	KLK1;ATP1B3;PRKACB;DNM1
MAPK signaling pathway	18/295	0.224120297657019	1.0	0	0	1.2203389830508475	1.8251052140397326	MAP2K3;PPP5D1;HSPA1L;CSF1;FLT3;NLK;CACNA1E;RELA;FGF3;MAPK8IP1;IKBKB;IL1B;MKNK1;FGF18;RAC2;PRKACB;FGFR3;SOS2
Shigellosis	5/65	0.2245509341987312	1.0	0	0	1.5384615384615385	2.2979272602185437	IKBKB;CTTN;ARPC3;UBE2D2;RELA
Cocaine addiction	4/49	0.22855481299593203	1.0	0	0	1.6326530612244896	2.4097619846443257	GRIN3A;PRKACB;RELA;GRIN1
Acute myeloid leukemia	5/66	0.23381942521025603	1.0	0	0	1.5151515151515151	2.201827497975576	IKBKB;FLT3;PIM1;SOS2;RELA
SNARE interactions in vesicular transport	3/34	0.24057000906593404	1.0	0	0	1.7647058823529411	2.5142543537821203	STX1B;STX16;YKT6
Chemokine signaling pathway	12/190	0.24303237414729376	1.0	0	0	1.263157894736842	1.786813411669786	SHC4;IKBKB;HCK;GRK2;GNB2;RAC2;CXCL14;PRKACB;JAK3;SOS2;RELA;GNG13
Prion diseases	3/35	0.25416276879858296	1.0	0	0	1.7142857142857142	2.3481949631326344	IL1B;C8B;PRKACB
Chagas disease (American trypanosomiasis)	7/103	0.2563521556372007	1.0	0	0	1.3592233009708736	1.8501790685021664	IKBKB;CASP8;IL1B;SERPINE1;PPP2R2D;TICAM1;RELA
Human immunodeficiency virus 1 infection	13/212	0.26377961818520207	1.0	0	0	1.2264150943396226	1.634371410639437	MAP2K3;APOBEC3D;RELA;GNG13;IKBKB;CASP8;AP1G1;GNB2;RAC2;ELOB;RIPK1;SKP1;ATR
Vitamin B6 metabolism	1/6	0.26493667555327055	1.0	0	0	3.333333333333333	4.427548139092615	PDXK
Wnt signaling pathway	10/158	0.2669520041494197	1.0	0	0	1.2658227848101267	1.6717549322539331	WNT10A;CCND2;DAAM2;RAC2;CSNK1E;PRICKLE1;NLK;LGR6;PRKACB;SKP1
Prolactin signaling pathway	5/70	0.2718688550208947	1.0	0	0	1.4285714285714284	1.860622113738027	SHC4;CCND2;ELF5;SOS2;RELA
Glycosaminoglycan biosynthesis	4/53	0.272750159994601	1.0	0	0	1.5094339622641508	1.9610551964847422	EXTL1;CHST15;ST3GAL2;HS6ST3
GABAergic synapse	6/89	0.2858516905884061	1.0	0	0	1.348314606741573	1.6884703375813395	GNB2;SLC6A13;PRKACB;GABRG3;GABRD;GNG13
Bile secretion	5/72	0.2913681345785638	1.0	0	0	1.3888888888888888	1.712732977852415	ATP1B3;SLC51B;BAAT;PRKACB;CYP7A1
p53 signaling pathway	5/72	0.2913681345785638	1.0	0	0	1.3888888888888888	1.712732977852415	CASP8;CCND2;SESN1;SERPINE1;ATR
Pathogenic Escherichia coli infection	4/55	0.2953729340320737	1.0	0	0	1.4545454545454544	1.773842236930121	KRT18;CTTN;TUBB3;ARPC3
Morphine addiction	6/91	0.303383440861158	1.0	0	0	1.3186813186813187	1.5728674181927342	GRK2;GNB2;PRKACB;GABRG3;GABRD;GNG13
Pyruvate metabolism	3/39	0.3093526636827237	1.0	0	0	1.5384615384615385	1.8050359176351607	FH;PKLR;ACYP2
Metabolism of xenobiotics by cytochrome P450	5/74	0.31110059336369467	1.0	0	0	1.3513513513513513	1.577890496988918	GSTM2;GSTO1;UGT2B17;MGST2;CYP2F1
TNF signaling pathway	7/110	0.3116404927590689	1.0	0	0	1.2727272727272725	1.4838791193422005	MAP2K3;IKBKB;CASP8;CSF1;IL1B;RIPK1;RELA
IL-17 signaling pathway	6/93	0.32110195783620454	1.0	0	0	1.2903225806451613	1.465802039518082	IKBKB;HSP90AB1;CASP8;IL1B;IL13;RELA
Ferroptosis	3/40	0.3232493972692518	1.0	0	0	1.4999999999999998	1.693996688892286	MAP1LC3A;GSS;ACSL6
NF-kappa B signaling pathway	6/95	0.33896434675202747	1.0	0	0	1.263157894736842	1.3665604407859686	IKBKB;CARD10;IL1B;RIPK1;TICAM1;RELA
FoxO signaling pathway	8/132	0.3401270250872685	1.0	0	0	1.2121212121212122	1.307195306601671	IKBKB;STK11;CCND2;BNIP3;CSNK1E;NLK;SGK2;SOS2
Antigen processing and presentation	5/77	0.34100404859306127	1.0	0	0	1.2987012987012985	1.397221985795033	CIITA;HSP90AB1;HSPA1L;PSME3;CTSS
Glutamatergic synapse	7/114	0.34418942042433864	1.0	0	0	1.2280701754385963	1.3098143731072236	GRK2;GRIN3A;GNB2;PRKACB;SHANK3;GNG13;GRIN1
alpha-Linolenic acid metabolism	2/25	0.3576694978288805	1.0	0	0	1.5999999999999999	1.645033455050064	FADS2;PLA2G2D
Hepatitis C	9/155	0.37149900230097443	1.0	0	0	1.1612903225806452	1.1499202456539444	IKBKB;CASP8;PSME3;EIF2AK1;PPP2R2D;RIPK1;TICAM1;SOS2;RELA
Estrogen signaling pathway	8/137	0.3782278714972952	1.0	0	0	1.167883211678832	1.1354842982136466	SHC4;HSP90AB1;KRT18;KRT39;HSPA1L;KRT20;PRKACB;SOS2
Insulin signaling pathway	8/137	0.3782278714972952	1.0	0	0	1.167883211678832	1.1354842982136466	SHC4;IKBKB;PKLR;PRKAR2B;MKNK1;TSC1;PRKACB;SOS2
Ubiquitin mediated proteolysis	8/137	0.3782278714972952	1.0	0	0	1.167883211678832	1.1354842982136466	UBOX5;UBA6;UBE2D2;UBE2QL1;WWP1;UBE2L6;ELOB;SKP1
Measles	8/138	0.38588815366024015	1.0	0	0	1.1594202898550725	1.1040089378109808	IKBKB;CCND2;CASP8;HSPA1L;EIF2AK1;IL1B;JAK3;RELA
Proteasome	3/45	0.3924009183942127	1.0	0	0	1.3333333333333333	1.2472949477860094	PSMB7;PSME3;PSMD3
Biosynthesis of unsaturated fatty acids	2/27	0.39397603610044213	1.0	0	0	1.4814814814814814	1.3799484349837585	FADS2;BAAT
NOD-like receptor signaling pathway	10/178	0.3989542659955018	1.0	0	0	1.1235955056179774	1.032481449693242	IKBKB;HSP90AB1;CASP8;IL1B;RIPK1;RBCK1;TICAM1;ANTXR1;MCU;RELA
Synthesis and degradation of ketone bodies	1/10	0.40133341390034794	1.0	0	0	2.0	1.8259254820662505	OXCT2
Longevity regulating pathway	6/102	0.4020193840167806	1.0	0	0	1.176470588235294	1.0720646736216428	STK11;HSPA1L;SESN1;TSC1;PRKACB;RELA
Type II diabetes mellitus	3/46	0.40605277189227273	1.0	0	0	1.3043478260869563	1.175572366691541	IKBKB;PKLR;CACNA1E
PI3K-Akt signaling pathway	19/354	0.4086462551538806	1.0	0	0	1.0734463276836157	0.9606329141882789	HSP90AB1;CSF1;FLT3;TSC1;RELA;FGF3;GNG13;IKBKB;STK11;CCND2;GNB2;FGF18;PPP2R2D;COL6A3;JAK3;SGK2;FGFR3;SOS2;EIF4B
Cysteine and methionine metabolism	3/47	0.4196120451603213	1.0	0	0	1.276595744680851	1.1086272722292005	SDS;GSS;MAT1A
Ether lipid metabolism	3/47	0.4196120451603213	1.0	0	0	1.276595744680851	1.1086272722292005	PLA2G2D;GDPD3;ENPP6
Ubiquinone and other terpenoid-quinone biosynthesis	1/11	0.43128166280518815	1.0	0	0	1.8181818181818181	1.529079804244035	VKORC1L1
Valine, leucine and isoleucine degradation	3/48	0.43306631871249	1.0	0	0	1.25	1.0460805021359667	DBT;OXCT2;HSD17B10
Fc epsilon RI signaling pathway	4/68	0.44400267624141365	1.0	0	0	1.176470588235294	0.9552055164674429	MAP2K3;IL13;RAC2;SOS2
Arginine and proline metabolism	3/49	0.44640402063272916	1.0	0	0	1.2244897959183672	0.987588809585937	CKM;LAP3;CKB
Citrate cycle (TCA cycle)	2/30	0.44657352514826887	1.0	0	0	1.3333333333333333	1.0748682963163632	FH;IDH3A
Pentose phosphate pathway	2/30	0.44657352514826887	1.0	0	0	1.3333333333333333	1.0748682963163632	GPI;ALDOB
Endocytosis	13/244	0.4475694451635287	1.0	0	0	1.0655737704918031	0.8566398681634505	HSPA1L;ZFYVE9;WWP1;VPS37A;DNM1;EEA1;GRK2;CAPZB;ARPC3;CHMP3;CHMP6;FGFR3;RAB8A
Human cytomegalovirus infection	12/225	0.4514330940391003	1.0	0	0	1.0666666666666667	0.8483499766033407	IKBKB;CASP8;IL1B;PTGER2;GNB2;RAC2;TSC1;RIPK1;PRKACB;SOS2;RELA;GNG13
Adipocytokine signaling pathway	4/69	0.45518892642326336	1.0	0	0	1.1594202898550725	0.9125133023815558	IKBKB;STK11;ACSL6;RELA
Cholesterol metabolism	3/50	0.4596144044474325	1.0	0	0	1.2	0.9328408706750739	ANGPTL3;LPA;CYP7A1
Circadian rhythm	2/31	0.46353362563600886	1.0	0	0	1.2903225806451613	0.9920985153401862	CSNK1E;SKP1
RIG-I-like receptor signaling pathway	4/70	0.4662992293725246	1.0	0	0	1.1428571428571428	0.8719174032140833	IKBKB;CASP8;RIPK1;RELA
Non-alcoholic fatty liver disease (NAFLD)	8/149	0.46993598574671025	1.0	0	0	1.0738255033557047	0.8109087721804916	IKBKB;CASP8;PKLR;COX4I1;IL1B;NDUFA10;COX7A1;RELA
Mineral absorption	3/51	0.47268752481329424	1.0	0	0	1.176470588235294	0.881553803378603	MT1F;ATP1B3;HMOX2
B cell receptor signaling pathway	4/71	0.47732691074516864	1.0	0	0	1.1267605633802817	0.8332999159019496	IKBKB;RAC2;SOS2;RELA
Fatty acid biosynthesis	1/13	0.48676267554205266	1.0	0	0	1.5384615384615385	1.107659375220991	ACSL6
Non-homologous end-joining	1/13	0.48676267554205266	1.0	0	0	1.5384615384615385	1.107659375220991	NHEJ1
Pathways in cancer	27/530	0.48849792368330275	1.0	0	0	1.0188679245283019	0.7299374174837857	FH;HSP90AB1;FLT3;PTGER2;MGST2;FGF3;RELA;IKBKB;CCND2;CASP8;PIM1;RAC2;ELOB;PRKACB;JAK3;SKP1;WNT10A;GSTM2;GSTO1;TXNRD2;IL13;GNG13;GNB2;FGF18;SOS2;FGFR3;F2RL3
Toxoplasmosis	6/113	0.4997075653239782	1.0	0	0	1.0619469026548671	0.7367067833785346	MAP2K3;IKBKB;CIITA;CASP8;HSPA1L;RELA
Bacterial invasion of epithelial cells	4/74	0.5098528753630284	1.0	0	0	1.0810810810810811	0.7282519724998587	SHC4;CTTN;ARPC3;DNM1
Inositol phosphate metabolism	4/74	0.5098528753630284	1.0	0	0	1.0810810810810811	0.7282519724998587	INPP1;PI4KA;SYNJ2;PLCD1
Chronic myeloid leukemia	4/76	0.531017425175643	1.0	0	0	1.0526315789473684	0.666274150005563	IKBKB;SHC4;SOS2;RELA
Pertussis	4/76	0.531017425175643	1.0	0	0	1.0526315789473684	0.666274150005563	C1S;IL1B;TICAM1;RELA
Hematopoietic cell lineage	5/97	0.5371052771771576	1.0	0	0	1.0309278350515463	0.6407846977351693	CSF1;FLT3;IL1B;GP1BA;CD34
Prostate cancer	5/97	0.5371052771771576	1.0	0	0	1.0309278350515463	0.6407846977351693	IKBKB;HSP90AB1;INSRR;SOS2;RELA
Starch and sucrose metabolism	2/36	0.5434764066615513	1.0	0	0	1.111111111111111	0.6775210926327332	GPI;PGM2L1
Alcoholism	9/180	0.5483170890648543	1.0	0	0	1.0	0.6009015296953345	SHC4;GRIN3A;H2AFY;GNB2;SOS2;HIST1H4E;CAMKK1;GNG13;GRIN1
Sphingolipid signaling pathway	6/119	0.5506572107989453	1.0	0	0	1.0084033613445378	0.6016565903086142	SGPL1;CERS5;PPP2R2D;RAC2;RELA;CERS2
Cellular senescence	8/160	0.5511758519618988	1.0	0	0	1.0	0.5957013701808717	MAP2K3;CCND2;SERPINE1;TSC1;MCU;RELA;RAD9A;ATR
Synaptic vesicle cycle	4/78	0.5517212852986342	1.0	0	0	1.0256410256410255	0.6099613109295229	STX1B;SLC6A13;DNM1;CPLX4
Primary immunodeficiency	2/37	0.5584386214472209	1.0	0	0	1.0810810810810811	0.6298492599382502	CIITA;JAK3
Complement and coagulation cascades	4/79	0.561890006637219	1.0	0	0	1.0126582278481011	0.5837459908567373	C1S;SERPINE1;C8B;F2RL3
AGE-RAGE signaling pathway in diabetic complications	5/100	0.5644459548061124	1.0	0	0	1.0	0.5719106399118082	IL1B;SERPINE1;PIM1;RELA;PLCD1
Inflammatory mediator regulation of TRP channels	5/100	0.5644459548061124	1.0	0	0	1.0	0.5719106399118082	MAP2K3;ASIC4;IL1B;PTGER2;PRKACB
Hepatitis B	8/163	0.5724547815603112	1.0	0	0	0.9815950920245399	0.5475548769053109	MAP2K3;IKBKB;EGR3;CASP8;TICAM1;JAK3;SOS2;RELA
Steroid hormone biosynthesis	3/60	0.5828910435264506	1.0	0	0	1.0	0.5397549994176116	DHRS11;UGT2B17;CYP7A1
Lysosome	6/123	0.5832741019158757	1.0	0	0	0.975609756097561	0.5259493126448419	AP3M1;AP1G1;PSAP;LAPTM5;CTSW;CTSS
Protein processing in endoplasmic reticulum	8/165	0.5863836234120163	1.0	0	0	0.9696969696969696	0.5176058726133539	DNAJB2;HSP90AB1;HSPA1L;UBE2D2;EIF2AK1;BAG1;RNF5;SKP1
Human papillomavirus infection	16/330	0.5868541173445081	1.0	0	0	0.9696969696969696	0.5168281332870329	PATJ;WNT10A;SCRIB;TSC1;TICAM1;RELA;IKBKB;CCND2;CASP8;NFX1;PPP2R2D;COL6A3;PRKACB;SOS2;LLGL2;ATR
Chemical carcinogenesis	4/82	0.591620653904691	1.0	0	0	0.975609756097561	0.5120874505494942	GSTM2;GSTO1;UGT2B17;MGST2
C-type lectin receptor signaling pathway	5/104	0.599573857726415	1.0	0	0	0.9615384615384616	0.49186164733317733	IKBKB;EGR3;CASP8;IL1B;RELA
Peroxisome	4/83	0.6012622374752512	1.0	0	0	0.963855421686747	0.4903364861494962	ECI2;PEX5;ACSL6;BAAT
Tight junction	8/170	0.6202201527232523	1.0	0	0	0.9411764705882353	0.4495819095842526	PATJ;STK11;CTTN;PPP2R2D;SCRIB;PRKACB;RAB8A;LLGL2
Glycosaminoglycan degradation	1/19	0.6228154838888618	1.0	0	0	1.0526315789473684	0.4984262922061619	HYAL2
Th17 cell differentiation	5/107	0.6248402405451496	1.0	0	0	0.9345794392523363	0.43949465144730016	IKBKB;HSP90AB1;IL1B;JAK3;RELA
Alzheimer disease	8/171	0.6268081564909365	1.0	0	0	0.935672514619883	0.4370664380599916	CASP8;COX4I1;IL1B;NDUFA10;ATP2A1;COX7A1;HSD17B10;GRIN1
Influenza A	8/171	0.6268081564909365	1.0	0	0	0.935672514619883	0.4370664380599916	MAP2K3;IKBKB;CIITA;HSPA1L;EIF2AK1;IL1B;TICAM1;RELA
Porphyrin and chlorophyll metabolism	2/42	0.6279256694973029	1.0	0	0	0.9523809523809523	0.4431747430401906	UGT2B17;HMOX2
Salmonella infection	4/86	0.6293463661035574	1.0	0	0	0.9302325581395349	0.4307660579611482	DYNC1LI1;ARPC3;IL1B;RELA
Drug metabolism	5/108	0.6330463554564062	1.0	0	0	0.9259259259259258	0.4233441001393671	GSTM2;GSTO1;UGT2B17;MGST2;ITPA
Relaxin signaling pathway	6/130	0.6372700870903559	1.0	0	0	0.9230769230769231	0.41590312126152085	SHC4;GNB2;PRKACB;SOS2;RELA;GNG13
Inflammatory bowel disease (IBD)	3/65	0.6374113112791769	1.0	0	0	0.9230769230769231	0.41569858263660475	IL1B;IL13;RELA
Mitophagy	3/65	0.6374113112791769	1.0	0	0	0.9230769230769231	0.41569858263660475	BNIP3;OPTN;RELA
Type I diabetes mellitus	2/43	0.6407574714002146	1.0	0	0	0.9302325581395349	0.41405046828616976	PTPRN2;IL1B
Aminoacyl-tRNA biosynthesis	3/66	0.6476960862533626	1.0	0	0	0.9090909090909091	0.3948488139467768	TARS2;FARSA;AARS
Fatty acid degradation	2/44	0.6532378269725155	1.0	0	0	0.9090909090909091	0.38710364483347576	ECI2;ACSL6
Glycosphingolipid biosynthesis	2/45	0.665369764985953	1.0	0	0	0.8888888888888888	0.3621443158089169	ST3GAL5;ST3GAL2
Amphetamine addiction	3/68	0.6676380497864279	1.0	0	0	0.8823529411764706	0.3564786122927678	GRIN3A;PRKACB;GRIN1
Glycolysis / Gluconeogenesis	3/68	0.6676380497864279	1.0	0	0	0.8823529411764706	0.3564786122927678	GPI;PKLR;ALDOB
Renal cell carcinoma	3/69	0.6772948191670352	1.0	0	0	0.8695652173913043	0.338824888725687	FH;ELOB;SOS2
Epstein-Barr virus infection	9/201	0.6798088518130012	1.0	0	0	0.8955223880597014	0.34562115277886923	IKBKB;MAP2K3;CCND2;CASP8;SIN3A;PSMD3;RIPK1;JAK3;RELA
Th1 and Th2 cell differentiation	4/92	0.6815826288475257	1.0	0	0	0.8695652173913043	0.333337208380493	IKBKB;IL13;JAK3;RELA
Mismatch repair	1/23	0.6928469690097347	1.0	0	0	0.8695652173913043	0.31908358966713624	POLD2
Proximal tubule bicarbonate reclamation	1/23	0.6928469690097347	1.0	0	0	0.8695652173913043	0.31908358966713624	ATP1B3
Renin-angiotensin system	1/23	0.6928469690097347	1.0	0	0	0.8695652173913043	0.31908358966713624	KLK1
Rap1 signaling pathway	9/206	0.7074277339148102	1.0	0	0	0.8737864077669902	0.3024347745654844	MAP2K3;CSF1;PRKD3;FGF18;RAC2;FGFR3;FGF3;GRIN1;F2RL3
Amoebiasis	4/96	0.7134178055156833	1.0	0	0	0.8333333333333333	0.28140670641508325	IL1B;C8B;PRKACB;RELA
Neurotrophin signaling pathway	5/119	0.7157855087234404	1.0	0	0	0.8403361344537815	0.2809871644732814	SHC4;IKBKB;ARHGDIG;SOS2;RELA
Kaposi sarcoma-associated herpesvirus infection	8/186	0.7176638068592711	1.0	0	0	0.8602150537634409	0.28537983239781983	IKBKB;HCK;CASP8;GNB2;CD200R1L;TICAM1;RELA;GNG13
Circadian entrainment	4/97	0.7210011321847114	1.0	0	0	0.8247422680412371	0.269785213526288	GNB2;PRKACB;GNG13;GRIN1
PPAR signaling pathway	3/74	0.722455815470999	1.0	0	0	0.8108108108108109	0.2635937966943547	FADS2;ACSL6;CYP7A1
Thyroid hormone synthesis	3/74	0.722455815470999	1.0	0	0	0.8108108108108109	0.2635937966943547	TPO;ATP1B3;PRKACB
Thermogenesis	10/231	0.72388661555566	1.0	0	0	0.8658008658008657	0.279758014899848	MAP2K3;KDM3A;COX4I1;NDUFA10;ACSL6;COX11;TSC1;PRKACB;COX7A1;SOS2
Apoptosis	6/143	0.7257137394923379	1.0	0	0	0.8391608391608392	0.26903466304887647	IKBKB;CASP8;RIPK1;CTSW;CTSS;RELA
Aldosterone synthesis and secretion	4/98	0.7284348779278988	1.0	0	0	0.8163265306122448	0.25865881578997496	MC2R;PRKD3;ATP1B3;PRKACB
Pancreatic secretion	4/98	0.7284348779278988	1.0	0	0	0.8163265306122448	0.25865881578997496	PLA2G2D;ATP1B3;ATP2A1;RAB8A
Calcium signaling pathway	8/188	0.7285867332092008	1.0	0	0	0.8510638297872339	0.269488172919229	STIM1;TACR2;ATP2A1;PRKACB;CACNA1E;MCU;PLCD1;GRIN1
Gastric acid secretion	3/75	0.7308710279969972	1.0	0	0	0.7999999999999999	0.2508146136696121	SLC9A4;ATP1B3;PRKACB
Pancreatic cancer	3/75	0.7308710279969972	1.0	0	0	0.7999999999999999	0.2508146136696121	IKBKB;RAC2;RELA
Amyotrophic lateral sclerosis (ALS)	2/51	0.7310789651903944	1.0	0	0	0.7843137254901961	0.24567356984329963	MAP2K3;GRIN1
Choline metabolism in cancer	4/99	0.7357196016371502	1.0	0	0	0.8080808080808081	0.24800501727640314	SLC22A3;RAC2;TSC1;SOS2
Phosphatidylinositol signaling system	4/99	0.7357196016371502	1.0	0	0	0.8080808080808081	0.24800501727640314	INPP1;PI4KA;SYNJ2;PLCD1
Maturity onset diabetes of the young	1/26	0.7367044256304639	1.0	0	0	0.7692307692307693	0.2350527061077511	PKLR
cAMP signaling pathway	9/212	0.738488191297845	1.0	0	0	0.8490566037735848	0.2573916514442508	MC2R;GRIN3A;GIPR;PTGER2;RAC2;ATP1B3;PRKACB;RELA;GRIN1
Hepatocellular carcinoma	7/168	0.7408637352815205	1.0	0	0	0.8333333333333333	0.2499488030031976	SHC4;WNT10A;GSTM2;GSTO1;TXNRD2;MGST2;SOS2
HIF-1 signaling pathway	4/100	0.7428559954663433	1.0	0	0	0.7999999999999999	0.23780245442692988	MKNK1;SERPINE1;ELOB;RELA
Ascorbate and aldarate metabolism	1/27	0.7498862689651448	1.0	0	0	0.7407407407407407	0.2132101669113366	UGT2B17
Cardiac muscle contraction	3/78	0.7549122409335416	1.0	0	0	0.7692307692307693	0.2162721335871487	COX4I1;ATP1B3;COX7A1
Retrograde endocannabinoid signaling	6/148	0.7553912967971983	1.0	0	0	0.8108108108108109	0.22744815412465288	GNB2;NDUFA10;PRKACB;GABRG3;GABRD;GNG13
Fanconi anemia pathway	2/54	0.7596159436572443	1.0	0	0	0.7407407407407407	0.2036609709042825	RMI2;ATR
Gastric cancer	6/149	0.7610356577983485	1.0	0	0	0.8053691275167785	0.21992622742208362	SHC4;WNT10A;CDX2;FGF18;SOS2;FGF3
Butanoate metabolism	1/28	0.7624087879510514	1.0	0	0	0.7142857142857142	0.19376600001083732	OXCT2
Osteoclast differentiation	5/127	0.7670589994510474	1.0	0	0	0.7874015748031495	0.20881225056066524	IKBKB;CSF1;IL1B;RELA;LILRB5
Autophagy	5/128	0.7729447333197296	1.0	0	0	0.78125	0.20120916351791152	STK11;BNIP3;ATG4C;TSC1;PRKACB
Linoleic acid metabolism	1/29	0.7743049289744676	1.0	0	0	0.689655172413793	0.17640656406412805	PLA2G2D
mTOR signaling pathway	6/152	0.7773915271524404	1.0	0	0	0.7894736842105262	0.19879828387763243	IKBKB;STK11;WNT10A;TSC1;SOS2;EIF4B
Viral carcinogenesis	8/201	0.7925273344506804	1.0	0	0	0.7960199004975124	0.18509714022296506	EGR3;CCND2;CASP8;SCRIB;PRKACB;JAK3;HIST1H4E;RELA
Asthma	1/31	0.7963417210162199	1.0	0	0	0.6451612903225806	0.1469205725810339	IL13
Mucin type O-glycan biosynthesis	1/31	0.7963417210162199	1.0	0	0	0.6451612903225806	0.1469205725810339	ST3GAL2
Viral myocarditis	2/59	0.8013529002820844	1.0	0	0	0.6779661016949152	0.15013820630777816	CASP8;RAC2
Propanoate metabolism	1/32	0.806540365201665	1.0	0	0	0.625	0.13437583301390715	DBT
Insulin secretion	3/86	0.8106028254070419	1.0	0	0	0.6976744186046511	0.14649563666446674	ATP1B3;KCNN3;PRKACB
Glycerolipid metabolism	2/61	0.8161634632362453	1.0	0	0	0.6557377049180327	0.1332069649091696	PNPLA3;LPIN2
Base excision repair	1/33	0.8162287694193023	1.0	0	0	0.6060606060606061	0.12306703553305594	POLD2
Fructose and mannose metabolism	1/33	0.8162287694193023	1.0	0	0	0.6060606060606061	0.12306703553305594	ALDOB
Apelin signaling pathway	5/137	0.8208780761188903	1.0	0	0	0.72992700729927	0.14407349424250715	MEF2A;GNB2;SERPINE1;PRKACB;GNG13
Gap junction	3/88	0.8227310669841436	1.0	0	0	0.6818181818181818	0.1330403886090264	TUBB3;PRKACB;SOS2
Pentose and glucuronate interconversions	1/34	0.8254324369271197	1.0	0	0	0.588235294117647	0.11285168470716885	UGT2B17
Protein digestion and absorption	3/90	0.8341902087803339	1.0	0	0	0.6666666666666666	0.120862556363351	COL5A1;COL6A3;ATP1B3
TGF-beta signaling pathway	3/90	0.8341902087803339	1.0	0	0	0.6666666666666666	0.120862556363351	ZFYVE9;SKP1;GDF7
Thyroid hormone signaling pathway	4/116	0.8378353080759515	1.0	0	0	0.689655172413793	0.1220232603840384	SIN3A;ATP1B3;PRKACB;PLCD1
Fc gamma R-mediated phagocytosis	3/91	0.8396768561291149	1.0	0	0	0.6593406593406593	0.11521197114942941	HCK;ARPC3;RAC2
mRNA surveillance pathway	3/91	0.8396768561291149	1.0	0	0	0.6593406593406593	0.11521197114942941	UPF2;PPP2R2D;CASC3
DNA replication	1/36	0.8424812699182175	1.0	0	0	0.5555555555555555	0.09522436030767889	POLD2
Tyrosine metabolism	1/36	0.8424812699182175	1.0	0	0	0.5555555555555555	0.09522436030767889	TPO
Central carbon metabolism in cancer	2/65	0.8428493095437481	1.0	0	0	0.6153846153846154	0.10521051812214251	FLT3;FGFR3
Cortisol synthesis and secretion	2/65	0.8428493095437481	1.0	0	0	0.6153846153846154	0.10521051812214251	MC2R;PRKACB
Parkinson disease	5/142	0.8437741668121552	1.0	0	0	0.704225352112676	0.11962703877312425	COX4I1;NDUFA10;UBE2L6;PRKACB;COX7A1
Non-small cell lung cancer	2/66	0.8489478345965421	1.0	0	0	0.6060606060606061	0.09924699267132996	JAK3;SOS2
GnRH signaling pathway	3/93	0.8501804853980194	1.0	0	0	0.6451612903225806	0.10471394598415903	MAP2K3;PRKACB;SOS2
African trypanosomiasis	1/37	0.8503713249208762	1.0	0	0	0.5405405405405406	0.08761198488762709	IL1B
Aldosterone-regulated sodium reabsorption	1/37	0.8503713249208762	1.0	0	0	0.5405405405405406	0.08761198488762709	ATP1B3
Huntington disease	7/193	0.8541653276195655	1.0	0	0	0.7253886010362693	0.11434337648580056	DNAH12;CASP8;SIN3A;COX4I1;NDUFA10;COX7A1;GRIN1
Long-term potentiation	2/67	0.8548301611907013	1.0	0	0	0.5970149253731343	0.0936432666623936	PRKACB;GRIN1
AMPK signaling pathway	4/120	0.8563810483662649	1.0	0	0	0.6666666666666666	0.10335990128643677	STK11;PPP2R2D;TSC1;RAB8A
Epithelial cell signaling in Helicobacter pylori infection	2/68	0.860502636162266	1.0	0	0	0.588235294117647	0.08837564694787858	IKBKB;RELA
Breast cancer	5/147	0.8642017469723211	1.0	0	0	0.6802721088435374	0.09928505713985045	SHC4;WNT10A;FGF18;SOS2;FGF3
Renin secretion	2/69	0.8659715129706728	1.0	0	0	0.5797101449275363	0.08342218313842696	PTGER2;PRKACB
Glycine, serine and threonine metabolism	1/40	0.8717504251826977	1.0	0	0	0.5	0.06862605284591321	SDS
Cell cycle	4/124	0.8730902649815165	1.0	0	0	0.6451612903225806	0.08755892398339275	CCND2;ESPL1;SKP1;ATR
Platelet activation	4/124	0.8730902649815165	1.0	0	0	0.6451612903225806	0.08755892398339275	STIM1;GP1BA;PRKACB;F2RL3
Oocyte meiosis	4/125	0.8769959948339774	1.0	0	0	0.64	0.08400182624919345	ESPL1;SPDYE1;PRKACB;SKP1
Progesterone-mediated oocyte maturation	3/99	0.8781684208695373	1.0	0	0	0.6060606060606061	0.07873750329026426	HSP90AB1;SPDYE1;PRKACB
Bladder cancer	1/41	0.878175666331951	1.0	0	0	0.4878048780487805	0.0633700633222169	FGFR3
Fat digestion and absorption	1/41	0.878175666331951	1.0	0	0	0.4878048780487805	0.0633700633222169	PLA2G2D
Graft-versus-host disease	1/41	0.878175666331951	1.0	0	0	0.4878048780487805	0.0633700633222169	IL1B
Homologous recombination	1/41	0.878175666331951	1.0	0	0	0.4878048780487805	0.0633700633222169	POLD2
Adherens junction	2/72	0.8812175551168138	1.0	0	0	0.5555555555555555	0.07025041245674381	RAC2;NLK
Melanoma	2/72	0.8812175551168138	1.0	0	0	0.5555555555555555	0.07025041245674381	FGF18;FGF3
Phagosome	5/152	0.8823360987788662	1.0	0	0	0.6578947368421052	0.08235673104394964	EEA1;DYNC1LI1;STX12;TUBB3;CTSS
T cell receptor signaling pathway	3/101	0.8864097011888528	1.0	0	0	0.594059405940594	0.07162931796059352	IKBKB;SOS2;RELA
Tuberculosis	6/179	0.8885227601225182	1.0	0	0	0.6703910614525139	0.07923688181265258	EEA1;CIITA;CASP8;IL1B;CTSS;RELA
Leishmaniasis	2/74	0.8904734986911036	1.0	0	0	0.5405405405405406	0.06270374958254536	IL1B;RELA
Cushing syndrome	5/155	0.892191742499279	1.0	0	0	0.6451612903225806	0.0735962655119009	MC2R;WNT10A;FH;WDR5;PRKACB
Glioma	2/75	0.8948461559431564	1.0	0	0	0.5333333333333333	0.0592551830845253	SHC4;SOS2
Carbohydrate digestion and absorption	1/44	0.8955853061573006	1.0	0	0	0.45454545454545453	0.05012627322480098	ATP1B3
Dopaminergic synapse	4/131	0.8983079302400212	1.0	0	0	0.6106870229007633	0.06549151922621713	GNB2;PPP2R2D;PRKACB;GNG13
Natural killer cell mediated cytotoxicity	4/131	0.8983079302400212	1.0	0	0	0.6106870229007633	0.06549151922621713	SHC4;RAC2;ULBP2;SOS2
ABC transporters	1/45	0.9008174591944802	1.0	0	0	0.4444444444444444	0.046423395514619575	ABCC11
Oxidative phosphorylation	4/133	0.9046524128561665	1.0	0	0	0.6015037593984962	0.060273373383263405	COX4I1;NDUFA10;COX11;COX7A1
Systemic lupus erythematosus	4/133	0.9046524128561665	1.0	0	0	0.6015037593984962	0.060273373383263405	H2AFY;C1S;C8B;HIST1H4E
Nucleotide excision repair	1/47	0.9105090567783704	1.0	0	0	0.42553191489361697	0.03989422673431822	POLD2
RNA degradation	2/79	0.9107606472852537	1.0	0	0	0.5063291139240506	0.047329191130890166	EXOSC4;XRN1
Insulin resistance	3/108	0.9114649563237461	1.0	0	0	0.5555555555555555	0.051501184313357255	IKBKB;SLC27A3;RELA
JAK-STAT signaling pathway	5/162	0.912456400890826	1.0	0	0	0.6172839506172839	0.0565524534028727	CCND2;IL13;PIM1;JAK3;SOS2
Regulation of actin cytoskeleton	7/214	0.9149059511108625	1.0	0	0	0.6542056074766354	0.058181124544326494	ARPC3;INSRR;FGF18;RAC2;FGFR3;SOS2;FGF3
Amino sugar and nucleotide sugar metabolism	1/48	0.914994048233663	1.0	0	0	0.41666666666666663	0.03701571599601437	GPI
Intestinal immune network for IgA production	1/48	0.914994048233663	1.0	0	0	0.41666666666666663	0.03701571599601437	MADCAM1
Malaria	1/49	0.919254474341766	1.0	0	0	0.4081632653061224	0.034364200583535946	IL1B
Ovarian steroidogenesis	1/49	0.919254474341766	1.0	0	0	0.4081632653061224	0.034364200583535946	PRKACB
ECM-receptor interaction	2/82	0.9211839178855769	1.0	0	0	0.4878048780487805	0.04004661901274316	COL6A3;GP1BA
Signaling pathways regulating pluripotency of stem cells	4/139	0.9216307962341534	1.0	0	0	0.5755395683453237	0.04697011427115409	WNT10A;HOXB1;FGFR3;JAK3
Vibrio cholerae infection	1/50	0.9233015685863551	1.0	0	0	0.39999999999999997	0.03191974852547144	PRKACB
Cholinergic synapse	3/112	0.9234195962447295	1.0	0	0	0.5357142857142857	0.04268118605193645	GNB2;PRKACB;GNG13
Taste transduction	2/83	0.9243958207118659	1.0	0	0	0.4819277108433735	0.03788670924051055	PRKACB;GNG13
Human T-cell leukemia virus 1 infection	7/219	0.925646181774397	1.0	0	0	0.639269406392694	0.04939200669208585	IKBKB;CCND2;ESPL1;PRKACB;JAK3;RELA;ATR
Serotonergic synapse	3/113	0.9261680268010687	1.0	0	0	0.5309734513274336	0.04072545470868394	GNB2;PRKACB;GNG13
ErbB signaling pathway	2/85	0.9304527474425885	1.0	0	0	0.47058823529411764	0.03392187580644571	SHC4;SOS2
Colorectal cancer	2/86	0.9333063042418757	1.0	0	0	0.46511627906976744	0.032103177510297835	RAC2;SOS2
Autoimmune thyroid disease	1/53	0.9342669389173686	1.0	0	0	0.3773584905660377	0.02565776594269266	TPO
MicroRNAs in cancer	10/299	0.934871967950476	1.0	0	0	0.668896321070234	0.04504728544673726	IKBKB;SHC4;CCND2;MIR10A;MIR26A2;PIM1;MIRLET7D;FGFR3;SOS2;MIR181A2
Adrenergic signaling in cardiomyocytes	4/145	0.9358455515330878	1.0	0	0	0.5517241379310345	0.03658197250531409	PPP2R2D;CREM;ATP1B3;PRKACB
Cell adhesion molecules (CAMs)	4/145	0.9358455515330878	1.0	0	0	0.5517241379310345	0.03658197250531409	CNTNAP1;ICAM3;MADCAM1;CD34
Herpes simplex virus 1 infection	18/492	0.9370892119869801	1.0	0	0	0.7317073170731706	0.04754399344708705	EIF2B5;ZNF792;EIF2B2;EIF2AK1;TSC1;TICAM1;RELA;IKBKB;ZFP14;CASP8;IL1B;ZNF227;ZNF304;ZNF425;ZNF268;ZNF334;ZNF234;ZNF212
Proteoglycans in cancer	6/201	0.9403516571166085	1.0	0	0	0.5970149253731343	0.03671723603686233	WNT10A;MIR10A;CTTN;PRKACB;SOS2;EIF4B
Regulation of lipolysis in adipocytes	1/55	0.9406924613791231	1.0	0	0	0.3636363636363636	0.022232368682920493	PRKACB
Phospholipase D signaling pathway	4/148	0.9420378113831829	1.0	0	0	0.5405405405405406	0.032275603102025825	SHC4;TSC1;SOS2;DNM1
Salivary secretion	2/90	0.9436483877912323	1.0	0	0	0.4444444444444444	0.025778512347182387	ATP1B3;PRKACB
Rheumatoid arthritis	2/91	0.9459848142593618	1.0	0	0	0.43956043956043955	0.024408247313871943	CSF1;IL1B
Endometrial cancer	1/58	0.9491734416512021	1.0	0	0	0.3448275862068965	0.017987494665677846	SOS2
Small cell lung cancer	2/93	0.9503836736321627	1.0	0	0	0.43010752688172044	0.021887960833825593	IKBKB;RELA
Ribosome	4/153	0.9511575630869465	1.0	0	0	0.5228758169934641	0.026183293427957225	RPS17;RPL3;RPL38;MRPL11
Lysine degradation	1/59	0.9517220547219089	1.0	0	0	0.3389830508474576	0.01677364276098951	KMT5B
VEGF signaling pathway	1/59	0.9517220547219089	1.0	0	0	0.3389830508474576	0.01677364276098951	RAC2
Glycerophospholipid metabolism	2/97	0.9581767039032599	1.0	0	0	0.41237113402061853	0.017617759662583495	PLA2G2D;LPIN2
Arachidonic acid metabolism	1/63	0.9607020222041087	1.0	0	0	0.31746031746031744	0.012727297981234762	PLA2G2D
Basal cell carcinoma	1/63	0.9607020222041087	1.0	0	0	0.31746031746031744	0.012727297981234762	WNT10A
Cytokine-cytokine receptor interaction	9/294	0.9610632781659656	1.0	0	0	0.6122448979591836	0.024315322048867823	CSF1;IL1B;IL13;TNFRSF8;TNFRSF25;RELT;CXCL14;GDF7;TNFRSF10D
Melanogenesis	2/101	0.9647890418591292	1.0	0	0	0.396039603960396	0.014196360797659355	WNT10A;PRKACB
Ribosome biogenesis in eukaryotes	2/101	0.9647890418591292	1.0	0	0	0.396039603960396	0.014196360797659355	UTP15;XRN1
Spliceosome	3/134	0.9665252718637258	1.0	0	0	0.4477611940298507	0.015245298295546113	RBM17;HSPA1L;SNRPA
Retinol metabolism	1/67	0.9680129340715097	1.0	0	0	0.29850746268656714	0.00970442691065804	UGT2B17
Staphylococcus aureus infection	1/68	0.9696175495526317	1.0	0	0	0.2941176470588235	0.009074577660222398	C1S
Parathyroid hormone synthesis, secretion and action	2/106	0.9716500119085215	1.0	0	0	0.3773584905660377	0.010852682798281577	MEF2A;PRKACB
Focal adhesion	5/199	0.9731949294049737	1.0	0	0	0.5025125628140703	0.013653707696236606	SHC4;CCND2;RAC2;COL6A3;SOS2
Neuroactive ligand-receptor interaction	10/338	0.9761366952206109	1.0	0	0	0.5917159763313609	0.014291506389086826	MC2R;GRIN3A;GIPR;PTGER2;TACR2;GABRG3;GABRD;MLN;GRIN1;F2RL3
Leukocyte transendothelial migration	2/112	0.9781900395096983	1.0	0	0	0.3571428571428571	0.007875469070295836	RAC2;RHOH
Transcriptional misregulation in cancer	4/186	0.9850692674529925	1.0	0	0	0.43010752688172044	0.0064702442990289336	CCND2;FLT3;SIN3A;RELA
Purine metabolism	2/129	0.9897423455563289	1.0	0	0	0.31007751937984496	0.0031970935628044842	PKLR;ITPA
cGMP-PKG signaling pathway	3/166	0.9906427254092609	1.0	0	0	0.36144578313253006	0.0033980706935995367	MEF2A;ATP1B3;ATP2A1
Dilated cardiomyopathy (DCM)	1/91	0.9907047643496917	1.0	0	0	0.21978021978021978	0.002052462844095697	PRKACB
Vascular smooth muscle contraction	2/132	0.9910345683579307	1.0	0	0	0.30303030303030304	0.0027290493823951636	PLA2G2D;PRKACB
Olfactory transduction	12/444	0.9945425426009739	1.0	0	0	0.5405405405405406	0.002958056066890534	GRK2;OR2G3;OR2H2;OR1L6;OR2B11;PRKACB;OR56A3;OR5B2;OR7D2;OR7A17;GNG13;OR3A1
Axon guidance	3/181	0.9949647355780132	1.0	0	0	0.3314917127071823	0.00167336488897828	RAC2;EPHB4;GDF7
Glucagon signaling pathway	1/103	0.9949913632524948	1.0	0	0	0.19417475728155337	9.749945649443491E-4	PRKACB
Oxytocin signaling pathway	1/153	0.9996182906586515	1.0	0	0	0.13071895424836602	4.9906171359877866E-5	PRKACB
